Comprehensive landscape of STEAP family functions and prognostic prediction value in glioblastoma

Glioblastoma (GBM) is the most common, malignant, and deadly primary glioma. Six‐transmembrane epithelial antigen of prostate (STEAP) family is involved in tumorigenesis; here, we have explored the biological function and the prognostic value of the STEAP family in GBM. Differentially expressed STEA...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cellular physiology 2021-04, Vol.236 (4), p.2988-3000
Hauptverfasser: Chen, Huaijun, Xu, Chaoran, Yu, Qian, Zhong, Chen, Peng, Yucong, Chen, Jingyin, Chen, Gao
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Glioblastoma (GBM) is the most common, malignant, and deadly primary glioma. Six‐transmembrane epithelial antigen of prostate (STEAP) family is involved in tumorigenesis; here, we have explored the biological function and the prognostic value of the STEAP family in GBM. Differentially expressed STEAP genes in tumor and normal samples were screened by using The Cancer Genome Atlas (TCGA) database. Univariate and multivariate Cox regression identified the prognosis‐related genes: STEAP2 and STEAP3, which were involved in the regulation of immune response and cell cycle. Finally, a prognostic nomogram combining age, gender, chemotherapy, radiotherapy, IDH1 status, and the risk score model based on STEAP2 and STEAP3 was built and further validated in TCGA and Chinese Glioma Genome Atlas (CGGA) cohorts via concordance index and calibration plot, which suggested a favorable value for prognosis prediction. In conclusion, our results provided a comprehensive analysis of the STEAP family and a model for the prognosis prediction of GBM. Graphical In this study, a prognostic model combining age, gender, chemotherapy, radiotherapy, IDH1 status, and the risk score based on STEAP2 and STEAP3 was built and further validated in The Cancer Genome Atlas and Chinese Glioma Genome Atlas cohorts, which showed a favorable value for prognosis prediction of GBM.
ISSN:0021-9541
1097-4652
DOI:10.1002/jcp.30060